Becton Dickinson Pty Ltd v B. Braun Melsungen AG

The case of Becton Dickinson Pty Ltd v B. Braun Melsungen AG involved a dispute over patent claims related to a catheter insertion device, with the central issue being whether certain claims were valid and infringed. The matter was heard in the Federal Court of Australia. The court was tasked with determining several legal issues, including the construction of the term "needle protective device" in the patent claims, whether the claims were entitled to a priority date from a prior application, if the claims were fairly based on the matter disclosed in the specification, and if the claims were valid and had not been rendered obvious by prior art.

In addressing these issues, the court examined the meaning of "needle protective device" and found that it did not include a blood control mechanism. The court also held that the claims were entitled to the priority date from the prior application and were fairly based on the matter disclosed in the specification. The court rejected the argument that the claims were invalid for lack of inventive step, as it found that the Fresenius blood control mechanism was not part of the common general knowledge in Australia as of the priority date. As a result, the court dismissed the originating application, the amended notice of cross-claim, and the amended notice of further cross-claim, and revoked certain claims in the patents in question.

The court ordered that the respondent prosecute any appeal expeditiously and serve copies of the orders on the Commissioner of Patents. The revocation of certain claims was stayed pending any appeal or its final determination. The parties were also directed to exchange brief written submissions on questions of costs. This decision clarified the scope of the patent claims and affirmed the validity of certain aspects of the patents in dispute.